About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

EMDR for Depressed People With Multiple Sclerosis | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT04875832

EMDR for Depressed People With Multiple Sclerosis

Several studies have reported high rates of depression in people with MS. Depressive symptoms represent a serious threat to quality of life and well-being. Furthermore, findings from the literature su...

Lead sponsor: Fondazione Don Carlo Gnocchi Onlus•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Fondazione Don Carlo Gnocchi Onlus

Collaborators

EMDR Europe
Catholic University of the Sacred Heart

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of relapsing-remitting or progressive MS.
•Presence of depressive symptomatology, with HADS scores \> 8, confirmed by HDRS scores (clinical interview) \> 14.
•No change of pharmacological treatment in the 3 months before the enrolment.
•Ability to communicate and to understand tasks.
•No clinical relapses or use of steroid treatment during the 4 weeks before the enrolment.
•Provided informed consent for study participation.

Exclusion Criteria

•Severe co-morbidity that would reduce life expectancy to less than one year (i.e. end-stage oncological diseases or severe cardiac dysfunction).
•Severe neuropsychological impairment evaluated with the MMSE.
•Psychosis or dissociative disorders.
•No current psychotherapy treatment
•Pregnancy.

Related studies

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT06433752 · Relapsing Multiple Sclerosis, Multiple Sclerosis

The Mom and Infant Outcomes (MOMI) Study

NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600 · Parents, Children With Disabilities, and more

RECRUITINGPhase 3

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

NCT06846281 · Relapsing Multiple Sclerosis

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 6, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment15

Start dateMay 2021

Last updatedMay 6, 2021

Condition

Multiple Sclerosis Depression

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 6, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions